These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15791457)

  • 41. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
    Allen C; Saigal K; Nottingham L; Arun P; Chen Z; Van Waes C
    Clin Cancer Res; 2008 Jul; 14(13):4175-85. PubMed ID: 18593997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.
    Benitez DA; Hermoso MA; Pozo-Guisado E; Fernández-Salguero PM; Castellón EA
    Prostate; 2009 Jul; 69(10):1045-54. PubMed ID: 19301309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
    Karthik S; Sankar R; Varunkumar K; Anusha C; Ravikumar V
    Biomed Pharmacother; 2015 Feb; 69():337-44. PubMed ID: 25661379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
    Wu JT; Kral JG
    J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
    Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
    Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells.
    Amaya K; Ohta T; Kitagawa H; Kayahara M; Takamura H; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2004 Oct; 25(4):849-56. PubMed ID: 15375532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
    Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
    Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
    Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
    J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer.
    Shah SA; Potter MW; McDade TP; Ricciardi R; Perugini RA; Elliott PJ; Adams J; Callery MP
    J Cell Biochem; 2001 Apr 2-27; 82(1):110-22. PubMed ID: 11400168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
    Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
    J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Proteasome inhibitor induces apoptosis and influences the expression of Notch1 and NF-kappaB in multiple myeloma RPMI8226 cells].
    Wang H; Liu X; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):531-7. PubMed ID: 18549623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo.
    Ito K; Kobayashi M; Kuroki S; Sasaki Y; Iwata T; Mori K; Kuroki T; Ozawa Y; Tetsuka M; Nakagawa T; Hiroi T; Yamamoto H; Ono K; Washizu T; Bonkobara M
    Vet J; 2013 Dec; 198(3):577-82. PubMed ID: 24035468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth-inhibitory effect of phosphatidylinositol 3-kinase inhibitor on human pancreatic cancer cells and expression of Bcl-2 family.
    Katayose K; Seki T; Ohba N; Funatomi H; Goto N; Mitamura K
    Anticancer Res; 2003; 23(3B):2383-7. PubMed ID: 12894518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells.
    Belardo G; Piva R; Santoro MG
    Leukemia; 2010 Jan; 24(1):187-96. PubMed ID: 19924145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NF-κB localization in multiple myeloma plasma cells and mesenchymal cells.
    Conticello C; Giuffrida R; Adamo L; Anastasi G; Martinetti D; Salomone E; Colarossi C; Amato G; Gorgone A; Romano A; Iannolo G; De Maria R; Giustolisi R; Gulisano M; Di Raimondo F
    Leuk Res; 2011 Jan; 35(1):52-60. PubMed ID: 20674018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent.
    An J; Sun Y; Fisher M; Rettig MB
    Mol Cancer Ther; 2004 Jun; 3(6):727-36. PubMed ID: 15210859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB.
    Lun M; Zhang PL; Pellitteri PK; Law A; Kennedy TL; Brown RE
    Ann Clin Lab Sci; 2005; 35(3):251-8. PubMed ID: 16081580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib.
    Cusack JC
    Cancer Treat Rev; 2003 May; 29 Suppl 1():21-31. PubMed ID: 12738240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
    Cvek B
    Hum Reprod; 2009 Nov; 24(11):2967; author reply 2967-8. PubMed ID: 19687055
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of proteasome inhibitor bortezomib on NF-kappaB activity and ICAM-1 mRNA expression of K562 cells].
    Lu SF; Lu H; Shen WY; Zhang JF; Liu P; Wang YR; Wang LX; Yang H; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1006-9. PubMed ID: 18928584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.